Global Value Chains Outlook 2026
Page 14 of 36 · WEF_Global_Value_Chains_Outlook_2026.pdf
Scaling COVID-19 vaccine production through modular design
Right after the COVID pandemic, BioNTech’s BioNTainer initiative introduced modular, containerized mRNA manufacturing
units that can be rapidly deployed and scaled globally. Each BioNTainer enables end-to-end vaccine production with
advanced automation and digital quality control. The standardized design allows replication and relocation within weeks,
ensuring rapid regional response to health crises.
Initial deployments in Rwanda and Senegal demonstrated how modular, intelligent manufacturing can strengthen
regional biomanufacturing capacity, shorten supply chains and enhance global health resilience by bringing production
closer to demand.13
IMPERATIVE IN ACTION 5
Global Value Chains Outlook 2026: Orchestrating Corporate and National Agility
14
Ask AI what this page says about a topic: